期刊论文详细信息
Journal of Neuroinflammation
The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis
Denis Gris1  Abdelaziz Amrani1  Subburaj Ilangumaran1  Diwakar Bobbala1  Echarki Zerif1  Pavel Gris2  Emilie Imbeault1  Tara M. Mahvelati1  Marjan Gharagozloo1 
[1] Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada;Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
关键词: Neuroinflammations;    Microglia;    Experimental autoimmune encephalomyelitis;    Nlrp12;   
Others  :  1230492
DOI  :  10.1186/s12974-015-0414-5
 received in 2015-06-26, accepted in 2015-10-19,  发布年份 2015
【 摘 要 】

Background

Multiple sclerosis (MS) is an organ-specific autoimmune disease resulting in demyelinating plaques throughout the central nervous system. In MS, the exact role of microglia remains unknown. On one hand, they can present antigens, skew T cell responses, and upregulate the expression of pro-inflammatory molecules. On the other hand, microglia may express anti-inflammatory molecules and inhibit inflammation. Microglia express a wide variety of immune receptors such as nod-like receptors (NLRs). NLRs are intracellular receptors capable of regulating both innate and adaptive immune responses. Among NLRs, Nlrp12 is largely expressed in cells of myeloid origins. It plays a role in immune inflammatory responses by negatively regulating the nuclear factor-kappa B (NF-κB) pathway. Thus, we hypothesize that Nlrp12 suppresses inflammation and ameliorates the course of MS.

Methods

We used experimental autoimmune encephalomyelitis (EAE), a well-characterized mouse model of MS. EAE was induced in wild-type (WT) and Nlrp12 −/− mice with myelin oligodendrocyte glycoprotein (MOG):complete Freud’s adjuvant (CFA). The spinal cords of healthy and immunized mice were extracted for immunofluorescence and pro-inflammatory gene analysis. Primary murine cortical microglia cell cultures of WT and Nlrp12 −/− were prepared with cortices of 1-day-old pups. The cells were stimulated with lipopolysaccharide (LPS) and analyzed for the expression of pro-inflammatory genes as well as pro-inflammatory molecule secretions.

Results

Over the course of 9 weeks, the Nlrp12 −/− mice demonstrated increased severity in the disease state, where they developed the disease earlier and reached significantly higher clinical scores compared to the WT mice. The spinal cords of immunized WT mice relative to healthy WT mice revealed a significant increase in Nlrp12 messenger ribonucleic acid (mRNA) expression at 1, 3, and 5 weeks post injection. A significant increase in the expression of pro-inflammatory genes Ccr5, Cox2, and IL-1β was found in the spinal cords of the Nlrp12 −/− mice relative to the WT mice (P < 0.05). A significant increase in the level of gliosis was observed in the spinal cords of the Nlrp12 −/− mice compared to the WT mice after 9 weeks of disease (P < 0.05). Primary Nlrp12 −/− microglia cells demonstrated a significant increase in inducible nitric oxide synthase (iNOS) expression (P < 0.05) and secreted significantly (P < 0.05) more tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), and nitric oxide (NO).

Conclusion

Nlrp12 plays a protective role by suppressing inflammation during the development of EAE. The absence of Nlrp12 results in an increased inflammatory response.

【 授权许可】

   
2015 Gharagozloo et al.

附件列表
Files Size Format View
Fig. 11. 18KB Image download
Fig. 10. 30KB Image download
Fig. 9. 10KB Image download
Fig. 8. 29KB Image download
Fig. 7. 14KB Image download
Fig. 6. 16KB Image download
Fig. 5. 16KB Image download
Figure 3. 89KB Image download
Fig. 3. 80KB Image download
Fig. 2. 20KB Image download
Fig. 1. 9KB Image download
Fig. 11. 18KB Image download
Fig. 10. 30KB Image download
Fig. 9. 10KB Image download
Fig. 8. 29KB Image download
Fig. 7. 14KB Image download
Fig. 6. 16KB Image download
Fig. 5. 16KB Image download
Fig. 4. 81KB Image download
Fig. 3. 80KB Image download
Fig. 2. 20KB Image download
Fig. 1. 9KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

Fig. 11.

Fig. 1.

Fig. 2.

Fig. 3.

Figure 3.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

Fig. 11.

【 参考文献 】
  • [1]Browning V, Joseph M, Sedrak M: Multiple sclerosis: a comprehensive review for the physician assistant. Jaapa 2012, 25:24-9.
  • [2]Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-17.
  • [3]Hemmer B, Kerschensteiner M, Korn T: Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol 2015, 14:406-19.
  • [4]Goverman J: Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009, 9:393.
  • [5]Ohsawa K, Imai Y, Sasaki Y, Kohsaka S: Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 2004, 88:844-56.
  • [6]Hernandez-Pedro NY, Espinosa-Ramirez G, de la Cruz VP, Pineda B, Sotelo J: Initial immunopathogenesis of multiple sclerosis: innate immune response. Clin Dev Immunol 2013, 2013:413465.
  • [7]David S, Kroner A: Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011, 12:388-99.
  • [8]Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune system. Int Rev Immunol 2011, 30:16-34.
  • [9]Tuncer S, Fiorillo MT, Sorrentino R: The multifaceted nature of NLRP12. J Leukoc Biol 2014, 96:991-1000.
  • [10]Kufer TA, Sansonetti PJ: NLR functions beyond pathogen recognition. Nat Immunol 2011, 12:121-8.
  • [11]Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009, 1:a001651.
  • [12]Gasparini C, Feldmann M: NF-kappaB as a target for modulating inflammatory responses. Curr Pharm Des 2012, 18:5735-45.
  • [13]Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Current protocols in immunology/edited by John E Coligan [et al.] 2007, CHAPTER:Unit-15.11.
  • [14]Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008, 3:1101-8.
  • [15]Brahmachari S, Fung YK, Pahan K: Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. The Journal of neuroscience 2006;26:4930-4939.
  • [16]Lukens JR, Gurung P, Shaw PJ, Barr MJ, Zaki MH, Brown SA, et al.: The NLRP12 sensor negatively regulates autoinflammatory disease by modulating interleukin-4 production in T Cells. Immunity 2015, 42:654-64.
  • [17]Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, et al.: Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol 2007, 178:1256-60.
  • [18]Williams KL, Lich JD, Duncan JA, Reed W, Rallabhandi P, Moore C, Kurtz S, Coffield VM, Accavitti-Loper MA, Su L: The CATERPILLER protein Monarch-1 is an antagonist of Toll-like receptor-, tumor necrosis factor α-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. Journal of Biological Chemistry 2005;280:39914-39924.
  • [19]Lich JD, Ting JP: Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. Microbes Infect 2007;9:672-676.
  • [20]Shami PJ, Kanai N, Wang LY, Vreeke TM, Parker CH: Identification and characterization of a novel gene that is upregulated in leukaemia cells by nitric oxide. Br J Haematol 2001;112:138-147.
  • [21]Smith KJ, Lassmann H: The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002;1:232-241.
  • [22]Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011;20:649–60.
  • [23]Arthur JC, Lich JD, Wilson JE, Ye Z, Allen IC, Gris D, et al. NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol. 2010;185:4515–9.
  • [24]Constantinescu CS, Farooqi N, O’Brien K, Gran B: Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 2011, 164:1079-106.
  • [25]Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, et al.: NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 2012, 36:742-54.
  • [26]Ye Z, Lich JD, Moore CB, Duncan JA, Williams KL, Ting JP: ATP binding by monarch-1/NLRP12 is critical for its inhibitory function. Mol Cell Biol 2008, 28:1841-50.
  • [27]Eitas TK, Chou WC, Wen H, Gris D, Robbins GR, Brickey J, et al.: The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation. J Biol Chem 2014, 289:4173-9.
  • [28]Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, et al.: The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 2010, 30:15811-20.
  • [29]Lira SA, Furtado GC: The biology of chemokines and their receptors. Immunol Res 2012, 54:111-20.
  • [30]Jiang Y, Salafranca MN, Adhikari S, Xia Y, Feng L, Sonntag MK, et al.: Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 1998, 86:1-12.
  • [31]Sorce S, Myburgh R, Krause KH: The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol 2011, 93:297-311.
  • [32]Zang YC, Samanta AK, Halder JB, Hong J, Tejada-Simon MV, Rivera VM, et al.: Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain 2000, 123(Pt 9):1874-82.
  • [33]Holman DW, Klein RS, Ransohoff RM: The blood–brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812, 2011:220-30.
  • [34]Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, O'Banion MK: Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 2007, 27:9301-9.
  • [35]Larochelle C, Alvarez JI, Prat A: How do immune cells overcome the blood–brain barrier in multiple sclerosis? FEBS Lett 2011, 585:3770-80.
  • [36]Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, et al.: NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 2010, 185:974-81.
  • [37]Inoue M, Williams KL, Gunn MD, Shinohara ML: NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2012, 109:10480-5.
  • [38]Newton K, Dixit VM: Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 2012, 4:a006049.
  文献评价指标  
  下载次数:100次 浏览次数:5次